Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02588209 · ClinicalTrials.gov registry record · NA

Cognitive Screening and Cognitive Training in Seniors

A NA study of Mild Cognitive Impairment, sponsored by The University of Texas at Dallas.

Completed
Registry status
NA
Development phase
71
Enrollment target
1
Study location

NCT02588209: Completed NA study of Mild Cognitive Impairment, sponsored by The University of Texas at Dallas.

NCT02588209 is a NA study of Mild Cognitive Impairment that has completed, run by The University of Texas at Dallas. The registered enrollment target is 71 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02588209, a NA study of Mild Cognitive Impairment, has completed, sponsored by The University of Texas at Dallas.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
1
Study location

Study Summary

This study will provide cognitive screenings for seniors age 50 and older. It will also investigate the benefits of two different cognitive training programs for seniors who have lower baseline performance on memory and/or gist reasoning tests.

Primary Outcome

To examine short-term effects of treatment on cognition using neuropsychological measures

Conditions Studied

Interventions

  • BEHAVIORAL Brain Health Workshop
  • BEHAVIORAL Strategic Memory Advanced Reasoning Training

Study Locations (1)

Texas

  • UTD Center for BrainHealth - Dallas

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2012-01
Est. Completion 2017-12
Phase NA
The University of Texas at Dallas

50 total trials

What the finished NCT02588209 record still lists

NCT02588209 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Brain Health Workshop is the first listed.

NCT02588209 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT02588209 about?

NCT02588209 is a clinical study titled "Cognitive Screening and Cognitive Training in Seniors". This study will provide cognitive screenings for seniors age 50 and older. It will also investigate the benefits of two different cognitive training programs for seniors who have lower baseline performance on memory and/or gist reasoning tests.

What is the current status of trial NCT02588209?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2012-01. Estimated completion is 2017-12.

What conditions does trial NCT02588209 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment.

What interventions are being tested in trial NCT02588209?

The interventions under investigation include: Brain Health Workshop (BEHAVIORAL), Strategic Memory Advanced Reasoning Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02588209?

This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02588209 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02588209's enrollment target sits among peer trials

71 115th of 205 higher than 91 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05452889 · 71 participants · Early Phase 1

    PET Image in PAH Patients

  • NCT05766943 · 71 participants · NA

    Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

  • NCT06229678 · 71 participants · Early Phase 1

    Ketones, SGLT2, HFrEF

  • NCT06377566 · 71 participants · Phase 2

    A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02588209, the US trial registry maintained by the National Library of Medicine. NCT02588209 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.